Article info

PDF
The development or worsening of hypertension after transcatheter aortic valve replacement (TAVR) improves short-term and long-term patient outcomes

Authors

  1. Correspondence to Dr Brent J Klinkhammer, University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND 58202, USA; brent.klinkhammer{at}unmc.edu
View Full Text

Citation

Klinkhammer BJ, Dyke CM, Haldis TA
The development or worsening of hypertension after transcatheter aortic valve replacement (TAVR) improves short-term and long-term patient outcomes

Publication history

  • Received December 26, 2017
  • Revised April 19, 2018
  • Accepted April 20, 2018
  • First published May 7, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.